CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 80.96% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

Cigna beats Q3 adjusted revenue on segment growth, raises FY outlook

By Reuters News


Overview

  • US health insurer's Q3 adjusted revenue rose yr/yr, beating analyst expectations

  • Adjusted income from operations per share was stable yr/yr at $7.98

  • Company raised 2026 outlook for adjusted income from operations to at least $30.60 per share


Outlook

  • Cigna raises 2026 adjusted income from operations outlook to at least $30.60 per share

  • Company expects 2026 Evernorth adjusted income from operations, pre-tax of at least $6.9 bln

  • Cigna Healthcare 2026 medical care ratio outlook narrowed to 84.2% plus or minus 25 bps


Result Drivers

  • SEGMENT GROWTH - Q3 revenue growth was driven by increases in both Evernorth Health Services and Cigna Healthcare

  • PHARMACY CLIENT TRANSITIONS - Lower pharmacy customer numbers reflected expected client transitions and reduced membership from health plan clients

  • SPECIALTY BUSINESS GROWTH - Specialty and Care Services saw strong organic growth, including higher biosimilar and specialty generic adoption


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

$73.68 bln

Q3 Adjusted Revenue

Beat

$73.79 bln

$72.72 bln (17 Analysts)

Q3 EPS

$5.47


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 18 "strong buy" or "buy", 9 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the managed healthcare peer group is "buy"

  • Wall Street's median 12-month price target for The Cigna Group is $339.00, about 11% above its November 4 closing price of $305.41

  • The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 9 three months ago


Reuters Recommended Reads

  • Nov 5 - Cigna raises annual profit forecast on strength in health services unit

  • Nov 4 - CVS to break up $117 billion business, separating pharmacies from insurance; shares fall

  • Nov 4 - Health insurers, hospitals rally after sweeping midterm win for Democrats


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.